| Fecha | Hora | Fuente | Título | Símbolo | Compañía |
| 14/02/2019 | 16:25 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 31/12/2018 | 09:37 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 27/12/2018 | 05:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 21/12/2018 | 11:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 21/12/2018 | 10:56 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 21/12/2018 | 10:51 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 21/12/2018 | 10:47 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 21/12/2018 | 07:47 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 20/12/2018 | 08:44 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 20/12/2018 | 08:25 | GlobeNewswire Inc. | Endocyte Stockholders Approve Merger Agreement with Novartis AG | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 12/12/2018 | 15:17 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 16/11/2018 | 05:20 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 15/11/2018 | 15:19 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 08/11/2018 | 11:25 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 07/11/2018 | 15:01 | GlobeNewswire Inc. | Endocyte Provides Third Quarter 2018 Financial Results and Operational Update | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 06/11/2018 | 16:37 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 01/11/2018 | 09:33 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 31/10/2018 | 16:31 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (preliminary) (prem14a) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 19/10/2018 | 02:02 | Dow Jones News | Novartis Deal Reflects Stress on High-Value Drugs -- WSJ | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 18/10/2018 | 10:36 | Dow Jones News | These Guys Should Start a Hedge Fund | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 18/10/2018 | 07:50 | Dow Jones News | Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion -- 3rd Update | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 18/10/2018 | 03:40 | Dow Jones News | Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion -- 2nd Update | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 18/10/2018 | 02:35 | Dow Jones News | Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion -- Update | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 18/10/2018 | 00:58 | Dow Jones News | Novartis Raises Outlook, Announces Endocyte Acquisition | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 18/10/2018 | 00:10 | GlobeNewswire Inc. | Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 16/10/2018 | 15:22 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 03/10/2018 | 05:00 | GlobeNewswire Inc. | Endocyte becomes first Purdue startup to reach $1.5B in value | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 27/09/2018 | 07:01 | GlobeNewswire Inc. | Endocyte to Present at Two Investor Conferences on October 2nd | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 14/09/2018 | 15:01 | GlobeNewswire Inc. | Endocyte Announces Closing of Public Offering of Common Stock | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
| 12/09/2018 | 15:05 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:ECYT | Endocyte, Inc. (delisted) |
